These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3741481)
1. Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics. Seago A; Goss PE; Griggs LJ; Jarman M Biochem Pharmacol; 1986 Sep; 35(17):2911-6. PubMed ID: 3741481 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and pharmacokinetics of the N- and C-n-octyl analogues of pyridoglutethimide [3-ethyl-3-(4-pyridyl)piperidine-2,6-dione]: novel inhibitors of aromatase. Seago A; Baker MH; Houghton J; Leung CS; Jarman M Biochem Pharmacol; 1987 Feb; 36(4):573-7. PubMed ID: 3827945 [No Abstract] [Full Text] [Related]
3. Selective aromatase inhibition by pyridoglutethimide, an analogue of aminoglutethimide. Kitawaki J; Yamamoto T; Urabe M; Tamura T; Inoue S; Honjo H; Okada H Acta Endocrinol (Copenh); 1990 May; 122(5):592-8. PubMed ID: 2353556 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat. Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of metabolites of 3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione, a potential breast cancer drug. Poon GK; McCague R; Griggs LJ; Jarman M; Lewis IA J Chromatogr; 1991 Dec; 572(1-2):143-57. PubMed ID: 1818050 [TBL] [Abstract][Full Text] [Related]
6. Analogues of aminoglutethimide: selective inhibition of aromatase. Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN; Plevey RG; Sampson P J Med Chem; 1985 Feb; 28(2):200-4. PubMed ID: 3968684 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metabolite. Jarman M; Foster AB; Goss PE; Griggs LJ; Howe I; Coombes RC Biomed Mass Spectrom; 1983 Nov; 10(11):620-5. PubMed ID: 6689274 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolites. Foster AB; Griggs LJ; Howe I; Jarman M; Leung CS; Manson D; Rowlands MG Drug Metab Dispos; 1984; 12(4):511-6. PubMed ID: 6148221 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism. Goss PE; Jarman M; Griggs LJ Br J Cancer; 1985 Feb; 51(2):259-62. PubMed ID: 3838134 [TBL] [Abstract][Full Text] [Related]
10. Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents. Leung CS; Rowlands MG; Jarman M; Foster AB; Griggs LJ; Wilman DE J Med Chem; 1987 Sep; 30(9):1550-4. PubMed ID: 3625703 [TBL] [Abstract][Full Text] [Related]
11. Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients. Dowsett M; MacNeill F; Mehta A; Newton C; Haynes B; Jones A; Jarman M; Lonning P; Powles TJ; Coombes RC Br J Cancer; 1991 Nov; 64(5):887-94. PubMed ID: 1931611 [TBL] [Abstract][Full Text] [Related]
12. Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage. Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN J Med Chem; 1983 Jan; 26(1):50-4. PubMed ID: 6827528 [TBL] [Abstract][Full Text] [Related]
13. Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives. McCague R; Rowlands MG J Med Chem; 1992 Oct; 35(20):3699-704. PubMed ID: 1433182 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer. Haynes BP; Jarman M; Dowsett M; Mehta A; Lønning PE; Griggs LJ; Jones A; Powles T; Stein R; Coombes RC Cancer Chemother Pharmacol; 1991; 27(5):367-72. PubMed ID: 1847846 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of aromatase activity in the rat by aminoglutethimide and related compounds. Pourgholami MH; Nicholls PJ; Smith HJ; Daly MJ; Dyas J J Steroid Biochem; 1987 Mar; 26(3):309-12. PubMed ID: 3586648 [TBL] [Abstract][Full Text] [Related]
16. Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives. Laughton CA; McKenna R; Neidle S; Jarman M; McCague R; Rowlands MG J Med Chem; 1990 Sep; 33(9):2673-9. PubMed ID: 2391706 [TBL] [Abstract][Full Text] [Related]
17. Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity. Rowlands MG; Bunnett MA; Foster AB; Jarman M; Stanek J; Schweizer E J Med Chem; 1988 May; 31(5):971-6. PubMed ID: 3361583 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione. Daly MJ; Jones GW; Nicholls PJ; Smith HJ; Rowlands MG; Bunnett MA J Med Chem; 1986 Apr; 29(4):520-3. PubMed ID: 3754286 [TBL] [Abstract][Full Text] [Related]
19. 1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase. Seago A; Baker MH; Houghton J; Jarman M; Leung CS; Rowlands MG Biochem Pharmacol; 1988 Jun; 37(11):2167-72. PubMed ID: 3377817 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of aminoglutethimide in the rat. Egger H; Bartlett F; Itterly W; Rodebaugh R; Shimanskas C Drug Metab Dispos; 1982; 10(4):405-12. PubMed ID: 6126342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]